Average Co-Inventor Count = 2.90
ph-index = 23
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amunix Operating Inc. (21 from 24 patents)
2. Affymax Technologies, N.v. (8 from 88 patents)
3. Maxygen, Inc. (6 from 124 patents)
4. Glaxo Group Limited (2 from 1,168 patents)
5. Amunix Pharmaceuticals, Inc (2 from 9 patents)
6. Affymetrix, Inc. (1 from 560 patents)
7. Bioverativ Therapeutics Inc. (1 from 71 patents)
8. Novozymes A/s (1,371 patents)
9. Biogen Ma Inc. (250 patents)
40 patents:
1. 12071456 - Extended recombinant polypeptides and compositions comprising same
2. 10961287 - Extended recombinant polypeptides and compositions comprising same
3. 10421798 - Factor VIII compositions and methods of making and using same
4. 10000543 - Glucose-regulating polypeptides and methods of making and using same
5. 9938331 - Biologically active proteins having increased in vivo and/or in vitro stability
6. 9926351 - Extended recombinant polypeptides and compositions comprising same
7. 9849188 - Growth hormone polypeptides and methods of making and using same
8. 9758776 - Coagulation factor IX compositions and methods of making and using same
9. 9540430 - Glucose-regulating polypeptides and methods of making and using same
10. 9376672 - Coagulation factor IX compositions and methods of making and using same
11. 9371369 - Extended recombinant polypeptides and compositions comprising same
12. 9249211 - Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same
13. 9168312 - Growth hormone polypeptides and methods of making and using same
14. 9062299 - Coagulation factor IX compositions and methods of making and using same
15. 8957021 - Glucose-regulating polypeptides and methods of making and using same